Agilent Technologies, Inc. (NYSE:A) Stock Rated “Moderate Buy” by Wall Street Brokerages

Agilent Technologies, Inc. (NYSE:A) has been given a consensus rating of “Moderate Buy” by the twenty-two research firms that are covering the company, MarketBeat.com reports. Four research analysts have rated the stock with a hold rating and eighteen have issued a buy rating on the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $181.45.

Several equities research analysts recently weighed in on the stock. Robert W. Baird increased their target price on shares of Agilent Technologies from $180.00 to $195.00 and gave the company an “outperform” rating in a research note on Thursday, October 8th. Bank of America upped their price objective on Agilent Technologies from $180.00 to $190.00 in a research note on Friday, October 9th. JPMorgan Chase & Co. increased their target price on shares of Agilent Technologies from $190.00 to $195.00 in a research report on Wednesday, October 14th. Citigroup increased their target price on shares of Agilent Technologies from $185.00 to $190.00 and gave the stock a “buy” rating in a research report on Thursday, August 27th. Finally, Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Saturday, October 17th.

Agilent Technologies Trading Up 1.0%

Shares of A stock opened at $177.80 on Wednesday. Agilent Technologies has a 12 month low of $108.35 and a 12 month high of $179.10. The stock has a 50 day moving average of $162.57 and a 200-day moving average of $135.93.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, beating analysts’ consensus estimates of $1.49 by $0.13. The company had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.84 billion. Agilent Technologies’s revenue for the quarter was up 8.1% on a year-over-year basis. During the same period last year, the company earned $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. As a group, sell-side analysts expect that Agilent Technologies will post 6.20 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 28th. Stockholders of record on Tuesday, October 6th will be issued a dividend of $0.2550 per share. The ex-dividend date of this dividend is Tuesday, October 6th. This represents a $1.02 annualized dividend and a dividend yield of 0.6%.

Insiders Place Their Bets

In other news, Director Mikael Dolsten sold 634 shares of the stock in a transaction on Friday, September 4th. The stock was sold at an average price of $151.38, for a total transaction of $95,974.92. Following the sale, the director owned 4,924 shares in the company, valued at approximately $745,395.12. This represents a 11.41% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Hedge Funds Weigh In On Agilent Technologies

A number of institutional investors have recently modified their holdings of A. SHP Wealth Management acquired a new stake in shares of Agilent Technologies in the fourth quarter valued at approximately $26,000. Markowski Investments acquired a new position in Agilent Technologies during the 2nd quarter worth $27,000. Cedar Mountain Advisors LLC acquired a new position in Agilent Technologies during the 1st quarter worth $27,000. Keating Financial Advisory Services Inc. bought a new position in Agilent Technologies in the 2nd quarter valued at $31,000. Finally, MidFirst Bank bought a new position in Agilent Technologies in the 4th quarter valued at $33,000.

About Agilent Technologies

Agilent Technologies, Inc is a global provider of analytical laboratory instruments, software, services and consumables. The company serves customers in the pharmaceutical, biotechnology, chemical, food, environmental, energy and academic research sectors, as well as diagnostic and clinical laboratories.

Agilent’s offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic instruments, laboratory automation products, genomic and cell analysis solutions, and related software.